King Luther Capital Management Corp Novartis Ag Transaction History

King Luther Capital Management Corp

$21.9 Billion
Q1 2024

A detailed history of King Luther Capital Management Corp transactions in Novartis Ag stock. As of the latest transaction made, King Luther Capital Management Corp holds 9,067 shares of NVS stock, worth $965,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,067

Previous 8,187 10.75%

Holding current value

$965,091

Previous $826,000 6.17%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $83,837 - $95,453	880 Added 10.75%	9,067 $877,000
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $14,670 - $16,144	-159 Reduced 1.91%	8,187 $826,000
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $73,510 - $81,580	-776 Reduced 8.51%	8,346 $850,000
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $134,801 - $152,853	-1,457 Reduced 13.77%	9,122 $920,000
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $46,657 - $54,108	583 Added 5.83%	10,579 $973,000

Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $32,184 - $39,413	-426 Reduced 4.09%	9,996 $906,000
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $98,783 - $115,532	-1,324 Reduced 11.27%	10,422 $792,000
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $194,214 - $226,125	2,412 Added 25.84%	11,746 $993,000
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $26,596 - $30,085	-332 Reduced 3.43%	9,334 $819,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $179,723 - $198,733	-2,255 Reduced 18.92%	9,666 $845,000
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $407,918 - $474,558	-4,988 Reduced 29.5%	11,921 $975,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $552,184 - $609,903	6,478 Added 62.1%	16,909 $1.54 Million
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $364,811 - $430,215	-4,369 Reduced 29.52%	10,431 $892,000
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $105,082 - $127,102	-1,346 Reduced 8.34%	14,800 $1.4 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $170,029 - $188,370	-2,070 Reduced 11.36%	16,146 $1.4 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $55,032 - $61,947	-680 Reduced 3.6%	18,216 $1.59 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $253,069 - $354,554	-3,581 Reduced 15.93%	18,896 $1.56 Million
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $1.28 Million - $1.44 Million	15,139 Added 206.31%	22,477 $2.13 Million
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $267,066 - $328,697	3,542 Added 93.31%	7,338 $670,000
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $76,901 - $85,628	-1,044 Reduced 21.57%	3,796 $326,000
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $22,424 - $25,939	-335 Reduced 6.47%	4,840 $417,000
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $42,126 - $47,610	649 Added 14.34%	5,175 $391,000
Q1 2018 May 08, 2018	BUY	$70.39 - $84.15 $10,910 - $13,043	155 Added 3.55%	4,526 $366,000
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $4,122 - $4,425	57 Added 1.32%	4,371 $367,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $319,839 - $333,342	4,314	4,314 $370,000

Others Institutions Holding NVS

# of Institutions

1,346

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Account

King Luther Capital Management Corp Novartis Ag Transaction History